Articles from: Pharma industry news (Moreover)
 |
|
|
| Next Page
| |
| ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study (more) | 2012 01 30 |
|
|
|
| Hamilton Introduces Automated DNA Sample Enrichment Solution Using Roche 45 (more) | 2012 01 30 |
|
| BIOGEN IDEC INC.: Biogen Idec Appoints Kenneth DiPietro Executive Vice Pres (more) | 2012 01 30 |
|
| Kyp Technology Drives Industry Transformation at ePharma Summit (more) | 2012 01 30 |
|
| Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuti (more) | 2012 01 30 |
|
| ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study (more) | 2012 01 30 |
|
| Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuti (more) | 2012 01 30 |
|
| Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Tri (more) | 2012 01 30 |
|
| Evidence-based guideline: Antiepileptic drug selection for people with HIV/ (more) | 2012 01 30 |
|
| ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study (more) | 2012 01 30 |
|
| Endo Pharmaceuticals price target lowered to $48 from $54 at Jefferies (more) | 2012 01 30 |
|
| Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuti (more) | 2012 01 30 |
|
| Valeant Pharmaceuticals to Syndicate Senior Secured Term Loan Credit Facili (more) | 2012 01 30 |
|
| VALEANT PHARMACEUTICALS INTL INC: Valeant Pharmaceuticals to Syndicate Seni (more) | 2012 01 30 |
|
|
| TRICAST Hits Industry Milestone: Places $1.5 Billion in Pharmaceutical Cont (more) | 2012 01 30 |
|
|
| Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Tri (more) | 2012 01 30 |
|
| Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuti (more) | 2012 01 30 |
|
| Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuti (more) | 2012 01 30 |
|
| Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuti (more) | 2012 01 30 |
|
|
|
| Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Tri (more) | 2012 01 30 |
|
|
| Immediate hematological toxicity of linezolid in healthy volunteers with di (more) | 2012 01 30 |
|
| JOHNSON & JOHNSON : Joins Public and Private Partners in the Largest Coordi (more) | 2012 01 30 |
|
| JOHNSON & JOHNSON: Joins Public and Private Partners in the Largest Coordin (more) | 2012 01 30 |
|
| Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment (more) | 2012 01 30 |
|
|
|
|
| TNT EXPRESS : launches PharmaSafe, the all-in-one transport solution for te (more) | 2012 01 30 |
|
|
| Tumor antigen protein SART-3 and tumor antigen peptides thereof (more) | 2012 01 30 |
|
|
| Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment (more) | 2012 01 30 |
|
|
| Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment (more) | 2012 01 30 |
|
| Moisture resistant container systems for rapidly bioavailable dosage forms (more) | 2012 01 30 |
|
| Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment (more) | 2012 01 30 |
|
|
| Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment (more) | 2012 01 30 |
|
|
| Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment (more) | 2012 01 30 |
|
| TNT EXPRESS: launches PharmaSafe, the all-in-one transport solution for tem (more) | 2012 01 30 |
|
| Methods and compositions for increasing replication capacity of an influenz (more) | 2012 01 30 |
|
| Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment (more) | 2012 01 30 |
|
| Next Page
| |
